Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
about
Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysisSynthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).Structure-activity relationship of halophenols as a new class of protein tyrosine kinase inhibitors.N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetDesign, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agentsMeasuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies.Synthesis and evaluation of caged Garcinia xanthones.Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway.Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas.
P2860
Q33433315-41728065-8A46-4E67-9653-1371668CA088Q33636283-8BC8294C-07DA-476D-AA1D-FA8E015FF367Q35297431-0CFE0244-735D-4EEA-8AC3-305DC53A7F44Q36614871-5CDE2E9F-09A6-46A5-B41F-2CAD24DBC1ACQ36775982-6D4561A7-AB75-4006-AB63-9E57B35DFF8FQ38088804-569B43ED-099D-4DB4-A05E-3CCFB8901A65Q40179254-0F62961D-3427-4A9C-A604-26FD3D67B3B2Q42132001-E69CDF52-6DE8-4764-B622-39B8FA1413F2Q43258540-07F3C3A7-DE12-4328-9C93-49F8F01F57D0Q54311105-2E1FD652-B08D-49C1-93F3-31E120B498C7
P2860
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@ast
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@en
type
label
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@ast
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@en
prefLabel
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@ast
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@en
P1476
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
@en
P2093
Athanassios Giannis
Ralph Mazitschek
P304
P356
10.1016/J.CBPA.2004.06.009
P577
2004-08-01T00:00:00Z